Literature DB >> 21533003

Breast ductal lavage for assessment of breast cancer biomarkers.

Robert Treat Chatterton1, Noah P Parker, Mito Habe-Evans, Michele Bryk, Denise M Scholtens, Seema A Khan.   

Abstract

Lavage of the ductal systems of the breast provides fluid (DLF) containing hormones and products of hormone actions that may represent more accurately the composition of the breast than samples collected from blood or urine. The present study was undertaken to assess the presence of potential cancer biomarkers, their variation among individuals at high risk for breast cancer, and differences associated with menopause and tamoxifen treatment. Seventy seven tamoxifen-eligible subjects with a 5-year breast cancer risk estimate (Gail > 1.6%)(N = 53) or recently diagnosed breast cancer (N = 24) were offered tamoxifen therapy; those not accepting tamoxifen were under observation only. After six months, all subjects underwent ductal lavage (DL) in an unaffected breast. Estradiol (E2), estrone sulfate, androstenedione, dehydroepiandrosterone (DHEA), DHEA sulfate, progesterone, cathepsin D and epidermal growth factor (EGF) were measured in DLF by immunoassays. Data were expressed as the mass of analyte per mg of protein in DLF and normalized by natural log transformation. With the exception of DHEA, none of the analytes measured were significantly lower in postmenopausal women than in premenopausal women. The mean log(e) concentration difference in estradiol was 10.9%. Tamoxifen treatment for 6 months did not result in a significantly greater concentration of E2 or in any of the other analytes in DLF of pre- or postmenopausal women. The between-duct variance of the concentration of free steroids within the same breast averaged 51% less than that between subjects, and was similar to that of non-diffusible proteins. The maintenance of estradiol concentrations in the breast after menopause demonstrates the importance of local biosynthesis. The fact that DLF E2 does not reflect the high serum concentrations of E2 during tamoxifen treatment indicates that breast concentrations of estradiol may be under feedback control. Unlike studies of low risk populations, progesterone concentrations were not significantly less in postmenopausal than in premenopausal women. The similarity in variance of free steroids and protein analytes between ducts of a breast indicates little transfer of steroids between lobules.

Entities:  

Keywords:  Breast; Cancer; Hormones; Lavage; Risk

Mesh:

Substances:

Year:  2010        PMID: 21533003      PMCID: PMC3082955          DOI: 10.1007/s12672-010-0021-y

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  31 in total

Review 1.  Regulation of steroid sulphatase and oestradiol 17 beta-hydroxysteroid dehydrogenase in breast cancer.

Authors:  A Purohit; A Singh; M J Reed
Journal:  Biochem Soc Trans       Date:  1999-02       Impact factor: 5.407

2.  Estrogens in plasma and fatty tissue from breast cancer patients and women undergoing surgery for non-oncological reasons.

Authors:  M A Blankenstein; J Szymczak; J Daroszewski; A Milewicz; J H Thijssen
Journal:  Gynecol Endocrinol       Date:  1992-03       Impact factor: 2.260

3.  Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.

Authors:  D Couissi; V Dubois; C Remacle; E Schonne; A Trouet
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

4.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

5.  Sex hormones in postmenopausal women with breast cancer on tamoxifen.

Authors:  I Kostoglou-Athanassiou; K Ntalles; J Gogas; C Markopoulos; V Alevizou-Terzaki; P Athanassiou; E Georgiou; C Proukakis
Journal:  Horm Res       Date:  1997

Review 6.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

7.  Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma.

Authors:  J R Pasqualini; J Cortes-Prieto; G Chetrite; M Talbi; A Ruiz
Journal:  Int J Cancer       Date:  1997-03-17       Impact factor: 7.396

8.  Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Authors:  Stacey A Missmer; A Heather Eliassen; Robert L Barbieri; Susan E Hankinson
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

9.  Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: effect of oral contraceptives and hormone replacement.

Authors:  Robert T Chatterton; Angela S Geiger; Esnar T Mateo; Irene B Helenowski; Peter H Gann
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

10.  Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.

Authors:  V C Jordan; N F Fritz; S Langan-Fahey; M Thompson; D C Tormey
Journal:  J Natl Cancer Inst       Date:  1991-10-16       Impact factor: 13.506

View more
  5 in total

1.  Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Authors:  Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

2.  Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.

Authors:  Jennifer T Loud; Gretchen L Gierach; Timothy D Veenstra; Roni T Falk; Kathryn Nichols; Allison Guttmann; Xia Xu; Mark H Greene; Mitchell H Gail
Journal:  Breast Cancer Res Treat       Date:  2014-01-18       Impact factor: 4.872

Review 3.  Challenges to the measurement of estradiol: an endocrine society position statement.

Authors:  William Rosner; Susan E Hankinson; Patrick M Sluss; Hubert W Vesper; Margaret E Wierman
Journal:  J Clin Endocrinol Metab       Date:  2013-03-05       Impact factor: 5.958

4.  An Improved Breast Epithelial Sampling Method for Molecular Profiling and Biomarker Analysis in Women at Risk for Breast Cancer.

Authors:  David N Danforth; Andrew C Warner; Darawalee Wangsa; Thomas Ried; Dominik Duelli; Armando C Filie; Sheila A Prindiville
Journal:  Breast Cancer (Auckl)       Date:  2015-06-08

5.  Examination of Duct Physiology in the Human Mammary Gland.

Authors:  Dixie Mills; Ameer Gomberawalla; Eva J Gordon; Julie Tondre; Mitra Nejad; Tinh Nguyen; Janice M Pogoda; Jianyu Rao; Robert Chatterton; Susanne Henning; Susan M Love
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.